Expanding
PSMA
Disclaimer: This page describes planned areas of development. These capabilities are not available for sale or clinical use and have not been cleared or approved by the U.S. FDA or any other regulatory body.
How
No items found.
Key Features
No items found.
Audience Value Overview
Clinical Applications
DeepPSMA supports a wide range of clinical and research use cases — from initial diagnosis to treatment response monitoring — helping clinicians interpret PSMA-PET/CT scans with speed, precision, and confidence.
No items found.
94%
negative predictive value for identifying non-responders
4,56x
higher risk of progression for non-responders vs responders
2,1x
higher risk of death for non-responders vs responders
92%
Accuracy in PSMA-positive lesion detection
87%
Accuracy in TNM staging
99%
Accuracy in whole-body tumor quantification
Frequently asked questions
No items found.